Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example-Reference-Cited by-同舟云学术

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example

Published:2021-05 Issue: Volume:Volume 14 Page:569-577
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Kisor David F,Petry Natasha J^ORCID,Bright David R^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference73 articles.

1. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene–drug pairs across ambulatory care settings

2. Clinical pharmacogenetics implementation: Approaches, successes, and challenges

3. American Society of Health System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacogenomics. Am J Health Syst Pharm. 2015;72(7):579–581. doi:10.2146/sp150003.

4. The clinical pharmacogenetics implementation consortium (CPIC®). Guidelines. Available from: https://cpicpgx.org/guidelines/. Accessed February 28, 2021.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice;Human Genomics;2024-01-30

2. The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S;Pharmacy;2023-09-10

3. CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt;Journal of Epidemiology and Global Health;2023-05-18

4. An Integrated Multidisciplinary Circuit Led by Hospital and Community Pharmacists to Implement Clopidogrel Pharmacogenetics in Clinical Practice;Pharmacy;2023-04-17

5. Evidence on the Impact of Direct-to-Consumer Pharmacogenetic Testing;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023